TPP1 and acne: The observed safety profile of cerliponase alfa in this study was consistent with findings described previously for treated patients with classic CLN2 disease.26 Age may have influenced the rate of C acnes infections in this cohort, as acne is more frequent in adolescents owing to increased sebum production.